SEIZERT CAPITAL PARTNERS, LLC

Position in PAHC — Phibro Animal Health Corp

CIK 1134283 BIRMINGHAM, MI

Position in PAHC

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$271,578

-$267,238 QoQ

Shares Held

8,649

-78.7% QoQ

Ownership

0.021%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#120

of 207 holders

Holding Since

Dec 2021

5 quarters on record

Voting authority Sole 50% Shared 0% None 50%

Healthcare · as of Jun 30, 2026

SEIZERT CAPITAL PARTNERS, LLC holds $94,363,768 across 5 Drug Manufacturers - Specialty & Generic names. PAHC ranks #4 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	277,337	$46,742,377
2	UTHR	UNITED THERAPEUTICS Corp	76,828	$41,627,715
3	ZTS	Zoetis Inc.	78,252	$5,623,188
4	PAHC	Phibro Animal Health Corp This page	8,649	$271,578
5	BHC	Bausch Health Companies Inc.	20,063	$98,910

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$271,578	8,649	-78.7%	Shares	Sole	2026-08-05
2022-09-30	$538,816	40,543	+36.6%	Shares	Sole	2022-11-02
2022-06-30	$567,721	29,677	+55.6%	Shares	Sole	2022-08-04
2022-03-31	$380,446	19,070	0.0%	Shares	Sole	2022-05-03
2021-12-31	$389,409	19,070	—	Shares	Sole	2022-02-08
No filing history on record for this holder in this stock.